Pillstats
Rx only · Kit

Vancomycin Hydrochloride

Brands: Firvanq

3 ACTIVE SUPPLIERS — US
openFDA · updated weekly
US10 NDCs
3 active makers
UKComing
soon
CAComing
soon
AUComing
soon
EUComing
soon
RxCUI (US)11124
US makers3 labelers
Packages12
DEA / ScheduleNone

US acquisition costNADAC · per unit

Average across 9 priced NDCs. A benchmark of pharmacy acquisition cost — not a retail quote.

$0.204$0.408$0.613$0.817Sep 2025Mar 2026Jul 2026
$0.710
Latest avg · Jul 22, 2026
+108%
Since Sep 17, 2025
3
Active US suppliers
67%
Top-2 supplier share*

Medicaid dispensing volumeSDUD · per quarter

Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume — Medicaid only, not all-payer.

6831.4K2.0K2.7K2025 Q12025 Q22025 Q32025 Q42026 Q1
1.9K
Rx · 2026 Q1
356K
Units dispensed
-20%
Rx vs. year ago
5
Quarters · since 2025 Q1

Who makes it3 active · 0 exited

US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.

LabelerTypePackagesStatus
Azurity Pharmaceuticals, Inc.unknown4SUPPLYING
Wilshire Pharmaceuticals, Inc.unknown4SUPPLYING
Ascend Laboratories, LLCunknown4SUPPLYING

Regulatory & supply eventsFDA · US

Shortages, recalls, and registration changes attached to this drug concept.

  • Aug 24, 2021
    RECALLRecall (Class I): Firvanq (vancomycin hydrochloride for oral solution), Vancomycin 50 mg/mL Kit, Each Kit Includes: 1 bottle containing 7…

    Product Mix-up: Incorrect diluent component included in the kit. — Recalling firm: Azurity Pharmaceuticals, Inc. — USA nationwide